Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Next >>

Date	Time	Source	Headline	Symbol	Company
10/02/2019	9:20AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
10/01/2019	5:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
10/01/2019	5:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
10/01/2019	5:51PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
10/01/2019	5:49PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
10/01/2019	10:52AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
09/30/2019	9:26AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
09/30/2019	9:23AM	Dow Jones News	Form 8.3 - [AbbVie Inc.]	NYSE:ABBV	AbbVie Inc
09/27/2019	5:38PM	Dow Jones News	FTC Requests for More Information From AbbVie-Allergan Tie-Up	NYSE:ABBV	AbbVie Inc
09/27/2019	4:16PM	PR Newswire (US)	Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction	NYSE:ABBV	AbbVie Inc
09/27/2019	4:15PM	PR Newswire (US)	AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction	NYSE:ABBV	AbbVie Inc
09/27/2019	9:36AM	Dow Jones News	Form 8.3 - [Allergan Inc.]	NYSE:ABBV	AbbVie Inc
09/26/2019	8:00PM	PR Newswire (US)	AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatme...	NYSE:ABBV	AbbVie Inc
09/26/2019	4:51PM	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	NYSE:ABBV	AbbVie Inc
09/26/2019	4:41PM	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NYSE:ABBV	AbbVie Inc
09/26/2019	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
09/26/2019	12:19PM	Dow Jones News	AbbVie Shares Rise After Upgrade From Citigroup	NYSE:ABBV	AbbVie Inc
09/26/2019	10:34AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
09/25/2019	10:53AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
09/25/2019	9:00AM	PR Newswire (Canada)	VENCLEXTA®, un traitement de la leucémie lymphoïde chronique (LLC), est maintenant remboursé dans l'Ouest canadien	NYSE:ABBV	AbbVie Inc
09/25/2019	9:00AM	PR Newswire (Canada)	VENCLEXTA®, a treatment for chronic lymphocytic leukemia (CLL), now reimbursed across Western Canada	NYSE:ABBV	AbbVie Inc
09/24/2019	10:50AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
09/24/2019	8:45AM	InvestorWire	Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers	NYSE:ABBV	AbbVie Inc
09/23/2019	4:25PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
09/23/2019	10:44AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
09/23/2019	3:01AM	PR Newswire (US)	AbbVie to Present New and Updated Data From 22 Abstracts, Including Two Late-Breaking Abstracts for ABBV-951 and DUODOPA® (l...	NYSE:ABBV	AbbVie Inc
09/20/2019	11:41AM	Dow Jones News	Form 8.3 - [Allergan Plc]	NYSE:ABBV	AbbVie Inc
09/19/2019	5:19PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NYSE:ABBV	AbbVie Inc
09/19/2019	10:57AM	Dow Jones News	Form 8.3 - Allergan Plc	NYSE:ABBV	AbbVie Inc
09/18/2019	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Next >>

Ethema Health (PK)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Fannie Mae (QB)

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Kraig Biocraft Laborator... (QB)

Rennova Health (PK)

Elite Pharmaceuticals (QB)

RespireRx Pharmaceuticals (PK)

Net Savings Link (PK)

Delayed Upgrade Clock